跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
森福罗 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Pramipexole Dihydrochloride Sustained Release Tablets
Approved
化学药品
Pramipexole Dihydrochloride Sustained Release Tablets
Boehringer Ingelheim International GmbH
🇨🇳 National Medical Products Administration
Approval Date
May 22, 2024
Approval ID
8aKPf2K20Ud
Company
Boehringer Ingelheim International GmbH
Type
化学药品
Approval Details
Approval Id
8aKPf2K20Ud
Approval Number
国药准字HJ20140579
Generic Name
盐酸普拉克索缓释片
Generic Name En
Pramipexole Dihydrochloride Sustained Release Tablets
Trade Name
森福罗
Drug Type
化学药品
Dosage Form
片剂
Strength
0.75mg
Reg Date
2024-05-22
Expired Date
2029-05-21
Company Name
Boehringer Ingelheim International GmbH
Production Company Name
Rottendorf Pharma GmbH
Company Detail Path
/organization/boehringer-ingelheim-international-gmbh
Production Company Detail Path
/organization/rottendorf-pharma-gmbh
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
May 22, 2024
Approval ID
8aKPf2K20Ud
Type
化学药品
Back to NMPA Approvals
